- Home
- PLRX vs OKYO Comparison
PLRX vs OKYO Comparison
Compare PLRX & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- OKYO
- Stock Information
- Founded
- PLRX 2015
- OKYO 2007
- Country
- PLRX United States
- OKYO United Kingdom
- Employees
- PLRX N/A
- OKYO N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLRX Health Care
- OKYO Health Care
- Exchange
- PLRX Nasdaq
- OKYO Nasdaq
- Market Cap
- PLRX 93.3M
- OKYO 77.9M
- IPO Year
- PLRX 2020
- OKYO 2022
- Fundamental
- Price
- PLRX $1.57
- OKYO $2.22
- Analyst Decision
- PLRX Hold
- OKYO Strong Buy
- Analyst Count
- PLRX 11
- OKYO 1
- Target Price
- PLRX $3.93
- OKYO $7.00
- AVG Volume (30 Days)
- PLRX 608.9K
- OKYO 167.5K
- Earning Date
- PLRX 11-06-2025
- OKYO 07-18-2025
- Dividend Yield
- PLRX N/A
- OKYO N/A
- EPS Growth
- PLRX N/A
- OKYO N/A
- EPS
- PLRX N/A
- OKYO N/A
- Revenue
- PLRX N/A
- OKYO N/A
- Revenue This Year
- PLRX N/A
- OKYO N/A
- Revenue Next Year
- PLRX N/A
- OKYO N/A
- P/E Ratio
- PLRX N/A
- OKYO N/A
- Revenue Growth
- PLRX N/A
- OKYO N/A
- 52 Week Low
- PLRX $1.10
- OKYO $0.90
- 52 Week High
- PLRX $16.10
- OKYO $3.35
- Technical
- Relative Strength Index (RSI)
- PLRX 52.68
- OKYO 53.78
- Support Level
- PLRX $1.45
- OKYO $1.91
- Resistance Level
- PLRX $1.70
- OKYO $2.31
- Average True Range (ATR)
- PLRX 0.09
- OKYO 0.16
- MACD
- PLRX 0.02
- OKYO 0.03
- Stochastic Oscillator
- PLRX 51.77
- OKYO 77.09
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.